Literature DB >> 29063476

Fungal β-Glucan Activates the NLRP3 Inflammasome in Human Bronchial Epithelial Cells Through ROS Production.

Yanhua Huang1, Meng Hua2, Xuefan Cui3.   

Abstract

The nucleotide-binding domain and leucine-rich repeat protein 3 (NLRP3) inflammasome has developed as an important bridge between innate immune and infection recently, and has the ability to drive proteolytic procaspase-1 into bioactive caspase-1, then responsible for proteolytic processing of inflammatory cytokines IL-1β and IL-18. Fungal β-glucan, a major component of fungal cell wall, triggers inflammatory response in multiple immune cells, but rarely described in epithelial cells. Also, the relationship between fungal β-glucan and NLRP3 inflammasome is not clear yet. In this study, we first identified that curdlan, a large particulate β-glucan, could activate the NLRP3 inflammasome in LPS-primed human bronchial epithelial cells (HBECs). RT-PCR and Western Blot showed that curdlan upregulate the mRNA as well as intracellular protein expression of NLRP3 and IL-1β in HBECs, along with the activity of caspase-1, and the level of mature IL-1β in cell supernatants was higher by ELISA detection. Further studies demonstrated that the activation of NLRP3 inflammasome could be attenuated by NAC, an inhibitor of ROS. Thus, it indicated curdlan activate NLRP3 inflammasome through a pathway requiring ROS production in HBECs. These findings may provide a new therapeutic target, NLRP3 inflammasome, in invasive pulmonary fungal infections.

Entities:  

Keywords:  NLRP3 inflammasome; ROS; fungal β-glucan; human bronchial epithelial cells

Mesh:

Substances:

Year:  2018        PMID: 29063476     DOI: 10.1007/s10753-017-0674-6

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  43 in total

Review 1.  Inflammasome-IL-1-Th17 response in allergic lung inflammation.

Authors:  Anne-Gaelle Besnard; Dieudonnée Togbe; Isabelle Couillin; Zoming Tan; Song Guo Zheng; François Erard; Marc Le Bert; Valérie Quesniaux; Bernhard Ryffel
Journal:  J Mol Cell Biol       Date:  2011-12-06       Impact factor: 6.216

Review 2.  Initiation and perpetuation of NLRP3 inflammasome activation and assembly.

Authors:  Eric I Elliott; Fayyaz S Sutterwala
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

3.  Biofilm from a clinical strain of Cryptococcus neoformans activates the NLRP3 inflammasome.

Authors:  Guowei Lei; Mingkuan Chen; Hua Li; Jun-Ling Niu; Shuxian Wu; Liming Mao; Ailing Lu; Hongbin Wang; Wei Chen; Bin Xu; Qibin Leng; Cunshuan Xu; Guiwen Yang; Liguo An; Li-Ping Zhu; Guangxun Meng
Journal:  Cell Res       Date:  2013-04-09       Impact factor: 25.617

Review 4.  Does the current treatment of invasive fungal infection need to be reviewed?

Authors:  Almudena Martín-Peña; Manuela Aguilar-Guisado; José Miguel Cisneros
Journal:  Enferm Infecc Microbiol Clin       Date:  2013-04-12       Impact factor: 1.731

Review 5.  The NLRP3 inflammasome in kidney disease and autoimmunity.

Authors:  Holly L Hutton; Joshua D Ooi; Stephen R Holdsworth; A Richard Kitching
Journal:  Nephrology (Carlton)       Date:  2016-09       Impact factor: 2.506

Review 6.  Inflammasomes in liver diseases.

Authors:  Gyongyi Szabo; Timea Csak
Journal:  J Hepatol       Date:  2012-05-23       Impact factor: 25.083

Review 7.  Fungal infections in the ICU: advances in treatment and diagnosis.

Authors:  Gennaro De Pascale; Mario Tumbarello
Journal:  Curr Opin Crit Care       Date:  2015-10       Impact factor: 3.687

8.  Aspergillus fumigatus stimulates the NLRP3 inflammasome through a pathway requiring ROS production and the Syk tyrosine kinase.

Authors:  Najwane Saïd-Sadier; Eduardo Padilla; Gordon Langsley; David M Ojcius
Journal:  PLoS One       Date:  2010-04-02       Impact factor: 3.240

9.  Concerted activation of the AIM2 and NLRP3 inflammasomes orchestrates host protection against Aspergillus infection.

Authors:  Rajendra Karki; Si Ming Man; R K Subbarao Malireddi; Prajwal Gurung; Peter Vogel; Mohamed Lamkanfi; Thirumala-Devi Kanneganti
Journal:  Cell Host Microbe       Date:  2015-02-19       Impact factor: 21.023

10.  Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD.

Authors:  Antonino Di Stefano; Gaetano Caramori; Adam Barczyk; Chiara Vicari; Paola Brun; Andrea Zanini; Francesco Cappello; Elvira Garofano; Anna Padovani; Marco Contoli; Paolo Casolari; Andrew L Durham; Kian Fan Chung; Peter J Barnes; Alberto Papi; Ian Adcock; Bruno Balbi
Journal:  Thorax       Date:  2014-01-15       Impact factor: 9.139

View more
  5 in total

1.  Luteoloside Inhibits Proliferation and Promotes Intrinsic and Extrinsic Pathway-Mediated Apoptosis Involving MAPK and mTOR Signaling Pathways in Human Cervical Cancer Cells.

Authors:  Junli Shao; Chaoxi Wang; Linqiu Li; Hairong Liang; Juanxiu Dai; Xiaoxuan Ling; Huanwen Tang
Journal:  Int J Mol Sci       Date:  2018-06-05       Impact factor: 5.923

Review 2.  The inflammasomes, immune guardians at defence barriers.

Authors:  Pablo Palazon-Riquelme; Gloria Lopez-Castejon
Journal:  Immunology       Date:  2018-09-06       Impact factor: 7.397

Review 3.  Pathogenic Fungal Infection in the Lung.

Authors:  Zhi Li; Gen Lu; Guangxun Meng
Journal:  Front Immunol       Date:  2019-07-03       Impact factor: 7.561

4.  Caveolin-1 gene therapy inhibits inflammasome activation to protect from bleomycin-induced pulmonary fibrosis.

Authors:  Xin Lin; Michael Barravecchia; R Matthew Kottmann; Patricia Sime; David A Dean
Journal:  Sci Rep       Date:  2019-12-23       Impact factor: 4.379

5.  Aspergillus fumigatus Influences Gasdermin-D-Dependent Pyroptosis of the Lung via Regulating Toll-Like Receptor 2-Mediated Regulatory T Cell Differentiation.

Authors:  Wei Yan; Yi-Si Zhao; Ke Xie; Yu Xing; Fang Xu
Journal:  J Immunol Res       Date:  2021-06-14       Impact factor: 4.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.